Skip to content

Exercise and Virtual Reality Exposure Therapy for Acrophobia

Exercise and Virtual Reality Exposure Therapy for Acrophobia

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02361203
Enrollment
60
Registered
2015-02-11
Start date
2015-02-28
Completion date
2016-01-31
Last updated
2016-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fear of Heights

Brief summary

The purpose of this study is to determine whether aerobic exercise can enhance the effects of exposure therapy treatment for fear of heights.

Interventions

BEHAVIORALExercise

30 minutes of aerobic exercise on a treadmill at 80% of participant's heart rate reserve.

Sponsors

University of Texas at Austin
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 25 Years
Healthy volunteers
Yes

Inclusion criteria

* Age 18 to 25 * Speaks English fluently * Score of 80 or higher on the Acrophobia Questionnaire * SUDS rating of 50 or higher on the Behavioral Avoidance Test or complete refusal to comply with instructions due to intensity of fear * Passes the Physical Activity Readiness Questionnaire-Plus

Exclusion criteria

* Hearing or visually impaired * Currently receiving exposure-based treatment for acrophobia * Able to remain on floor 20 for 30 seconds during BAT with a SUDS rating \< 50

Design outcomes

Primary

MeasureTime frameDescription
Fear scores7 (+/- 3) days after exposure therapyChange in fear scores using subjective units of distress will be assessed.
Perceived threat likelihood scores7 (+/- 3) days after exposure therapyChange in the perception of threat likelihood on a scale from 1-5 will be assessed.

Secondary

MeasureTime frameDescription
Acrophobia Severity14 (+/- 3) days after exposure therapyChange in score on the Acrophobia Questionnaire
Skin conductance fluctuations7 (+/- 3) days after exposure therapyChanges in skin conductance fluctuations will be assessed.
Clinical Global Improvement14 (+/- 3) days after exposure therapyChange in score on the Clinical Global Improvement Scale
Attitudes Toward Heights14 (+/- 3) days after exposure therapyChange in score on the Attitudes Toward Heights Inventory
Heart rate fluctuations7 (+/- 3) days after exposure therapyHeart rate fluctuations will be assessed.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026